National Institute for Pharmaceutical Technology & Education (NIPTE)

Jinghan Li, University of Minnesota, is the recipient of the 2024 NIPTE Outstanding Student Research Award “Li Jinghan is an exceptionally talented scientist with impressive achievements early in his career. His academic portfolio boasts 16 peer-reviewed articles, with 10 as first or co-first author, and 22 presentations at both institutional and international conferences, including 4 oral presentations. His accolades include the U Minnesota Doctoral Dissertation Fellowship, the David and Marilyn Grant Fellowship, and the International Pharmaceutical Excipient Council Student Award, among others.” – Yongchao Su, Ph.D., FRSC, Principal Scientist, MERCK, and Adjunct Faculty, Purdue University Jinghan's scientific research spans small molecule solid dosage forms to large molecule formulations, with a deep focus on understanding molecular interactions and mechanisms. "I would like to express my gratitude to Drs. Raj Suryanarayanan and Yongchao Su for their nomination, and to the NIPTE committee members for selecting me as the Outstanding Student Researcher. My research focuses on the advanced characterization of drug-excipient and excipient-excipient interactions in small molecules and protein formulations, offering in-depth mechanistic insights for the design of stable drug products. Pharmaceutics is a fascinating field that I greatly enjoy working in, and I look forward to continually contributing to this area." – Jinghan Li, Award Recipient The NIPTE Outstanding Student Research Scholarship is awarded by the National Institute for Pharmaceutical Technology and Education on an annual basis. The award is given to graduate students with outstanding scientific achievements in the areas of pharmaceutical science and technology. Congratulations Jinghan Li on this well-deserved honor!

Dr. Diane Burgess, Pfizer Distinguished Chair in Pharmaceutical Technology, Board of Trustees Distinguished Professor, University of Connecticut School of Pharmacy, has been selected as the 2024 David J. W. Grant NIPTE Distinguished Scholar in Basic Pharmaceutics. Professor Burgess has dedicated her research efforts to advancing the field of basic pharmaceutics and drug delivery science, focusing on microspheres, nanoparticles, liposomes, emulsions, and hydrogels. Her work spans from fundamental colloid and interfacial chemistry to practical applications, resulting in over 280 refereed publications, book chapters, and patents as well as over 735 invited presentations at major scientific meetings. Dr. Burgess has also received numerous awards and recognitions. “Throughout her illustrious career, Dr. Burgess has fostered a nurturing, inclusive, and diverse research and training environment that has empowered numerous junior scientists to flourish and achieve success. Under her guidance, her students not only excel in their research pursuits but also hone invaluable leadership skills.” Philip M. Hritcko, Pharm.D., FCPA, Dean and Clinical Professor, University of Connecticut School of Pharmacy. The David J. W. Grant NIPTE Distinguished Scholar Award is the highest recognition awarded by the National Institute for Pharmaceutical Technology and Education on an annual basis. The award is given for outstanding scientific achievements in the relevant areas of pharmaceutical science and technology.

NIPTE Board Member & Outgoing Chair, Dr. Indra K. Reddy, named Founding Dean Emeritus of Irma Lerma Rangel School of Pharmacy, Texas A&M University The Texas A&M University System Board of Regents has honored Indra K. Reddy, PhD, with the prestigious title of Founding Dean Emeritus of the Texas A&M University Irma Lerma Rangel School of Pharmacy. This honor recognizes his distinguished and dedicated service during his illustrious 20-year tenure as the founding dean, during which he transformed the school into one of the nation's leading institutions. See press release: https://lnkd.in/gAGciM65 Reddy is the outgoing chair of The National Institute for Pharmaceutical Technology & Education's Board of Directors. NIPTE was fortunate to have him as our leader for the past three years. Congratulations to Dr. Reddy on this well-deserved honor! 

Updates to NIPTE's Leadership: NIPTE is pleased to announce that Dr. James Drennen, Duquesne University, will begin his three-year term as the board's 8th chair on July 1. Drennen is a long-time NIPTE member and leader. He currently serves as vice chair of the Board. Dr. Philip Hritcko, University of Connecticut, will now serve as the vice chair. In a joint statement, Drennen and NITPE’s Executive Director, Vadim Gurivch, stated, “It is time to reflect before we forge ahead. We must first recognize outgoing chair, Dr. Indra K, Reddy, Texas A&M University, for his outstanding leadership and unwavering dedication. Dr. Reddy played a significant role in shaping the NITPE strategy and direction, and thoughtfully helped to facilitate a plan for seamless transition.” Gurvich added that he especially appreciates Drennen’s continued leadership on the Board in this expanded role. “The Organization is in good hands as we set forth— building on the Board’s current vision while pursuing new initiatives and opportunities.” Congratulations Drs. Drennen and Hritcko.

The Critical Need for API—Achieving Pharmaceutical Independence in the US by Reshoring Active Pharmaceutical Ingredient Manufacturing Capabilities. Today, the US depends on imports from China and other overseas sources for a majority of the APIs used to make drug products critical to US patients. NIPTE announces the release of a new white paper on a strategy for mitigating this risk to the US pharmaceutical supply chain and the US population who depend on access to these life-saving medicines. Read the press release and the white paper. https://nipte.org/ https://lnkd.in/gr3hqHwM Vadim J. Gurvich, Ph.D., M.B.A., Fernando Muzzio, James K. Ferri, Frank Gupton #pharmaceuticalindependence

The Critical Need for API—Achieving Pharmaceutical Independence in the US by Reshoring Active Pharmaceutical Ingredient Manufacturing Capabilities. Today, the US depends on imports from China and other overseas sources for a majority of the APIs used to make drug products critical to US patients. NIPTE announces the release of a new white paper on a strategy for mitigating this risk to the US pharmaceutical supply chain and the US population who depend on access to these life-saving medicines. Read the press release and the white paper. https://nipte.org/ https://lnkd.in/gr3hqHwM Vadim J. Gurvich, Ph.D., M.B.A., Fernando Muzzio, James K. Ferri, Frank Gupton #pharmaceuticalindependence

NIPTE is proud to announce two new board members. Dr. Arash Dabestani and Dr. Barbara Timmermann. Dr. Dabestani will represent Long Island University and Dr. Timmermann will represent University of Kansas on NIPTE's Board of Directors. NIPTE wants to thank Dr. Michael Kinch (LIU) and Ronald Ragan (KU) for their extraordinary contributions and support to NIPTE during their tenure.

The National Institute of Pharmaceutical Technology and Education (NIPTE) is deeply grateful to the The Bush School of Government & Public Service - Washington, DC at Texas A&M University and its Executive Director, Lt. Gen. (Ret.) Jay Silveria for his outstanding commitment and support. Pictured here with Vadim J. Gurvich, Ph.D., M.B.A., Indra Reddy, and Jim Drennen, January 31, 2024.